Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL8087515 | 1.00 | TGFBR1 (0.32) | TGFBR1TDP1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL27649 | 1.00 | TGFBR1 (0.32) | TGFBR1TDP1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL11006034 | 1.00 | TGFBR1 (0.32) | TGFBR1TDP1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL1974753 | 1.00 | TGFBR1 (0.32) | TGFBR1TDP1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL443711 | 1.00 | TGFBR1 (0.32) | TGFBR1TDP1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL9194150 | 1.00 | TGFBR1 (0.32) | TGFBR1TDP1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL36868 | 1.00 | TGFBR1 (0.32) | TGFBR1TDP1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL1485968 | 1.00 | TGFBR1 (0.32) | TGFBR1TDP1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL4878336 | 1.00 | TGFBR1 (0.32) | TGFBR1TDP1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL23639 | 1.00 | TGFBR1 (0.32) | TGFBR1TDP1TET2ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1087 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4555021-B1 | UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX | BASF SE (DE) | 2026-05-13 | — | — | EP | claimed |
| US-12552956-B2 | Photopolymerizable type dental surface coating composition | SHOFU INC. (JP) | 2026-02-17 | — | — | US | claimed |
| US-20260008936-A1 | UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX | BASF SE (DE) | 2026-01-08 | — | — | US | claimed |
| EP-4665832-A1 | WELL PLATE FOR IMAGING | The University of British Columbia (CA) | 2025-12-24 | — | — | EP | claimed |
| EP-4555021-A1 | UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX | BASF SE (DE) | 2025-05-21 | — | — | EP | claimed |
| CN-119979038-A | Laminated battery packaging adhesive film, preparation method thereof and laminated battery assembly | 杭州福斯特应用材料股份有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119935801-A | Detection method for precipitation of POE resin particle auxiliary agent | 万华化学集团股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| EP-4337734-B1 | COMPOSITIONS, COMPRISING PLATELET-SHAPED TRANSITION METAL PARTICLES | BASF SE (DE) | 2025-04-23 | — | — | EP | claimed |
| WO-2025043950-A1 | POLYOLEFIN ELASTOMER AND USE THEREOF IN PHOTOVOLTAIC ENCAPSULATION FILM | 万华化学集团股份有限公司 | 2025-03-06 | — | — | WO | claimed |
| CN-116285725-B | Packaging adhesive film, composite glass and photovoltaic building integrated assembly | 杭州福斯特应用材料股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| EP-1678548-A2 | COMPOSITIONS AND METHODS FOR THE PREPARATION OF COMPOSITE PHOTOCHROMIC POLYCARBONATE LENSES | SIGNET ARMORLITE, INC. (US) | 2006-07-12 | — | — | EP | claimed |
| WO-2005043221-A2 | COMPOSITIONS AND METHODS FOR THE PREPARATION OF COMPOSITE PHOTOCHROMIC POLYCARBONATE LENSES | SIGNET ARMORLITE, INC. (US) | 2005-05-12 | — | — | WO | claimed |
| US-20040014837-A1 | Dimethylamine/ester adducts and their use in polymerizable compositions | SURFACE SPECIALTIES, S.A. (BE) | 2004-01-22 | — | — | US | claimed |
| US-6610426-B2 | Durability, smoothness, magnetic layer of uniform thickness, electromagnetic characteristics | FUJI PHOTO FILM CO., LTD. (JP) | 2003-08-26 | — | — | US | claimed |
| EP-1328505-A1 | DIMETHYLAMINE/ESTER ADDUCTS AND THEIR USE IN POLYMERIZABLE COMPOSITIONS | UCB, S.A. (BE) | 2003-07-23 | — | — | EP | claimed |
| US-20020122957-A1 | Magnetic recording medium | FUJIFILM CORPORATION (JP) | 2002-09-05 | — | — | US | claimed |
| WO-2002032851-A1 | DIMETHYLAMINE/ESTER ADDUCTS AND THEIR USE IN POLYMERIZABLE COMPOSITIONS | UCB, S.A. (BE) | 2002-04-25 | — | — | WO | claimed |
| EP-0716102-B1 | TRANSPARENT PLASTIC MATERIAL, OPTICAL ARTICLE MADE THEREFROM, AND PRODUCTION PROCESS | SEIKO EPSON CORP (JP) | 2002-02-06 | — | — | EP | claimed |
| US-4526920-A | Contains poly(meth)acrylic ester of oxy or polyoxyalkane polyol, polymerization initiator, filler | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1985-07-02 | — | — | US | claimed |
| US-3968309-A | Molded articles of plastics having improved surface characteristics and process for producing the same | DAINIPPON PRINTING CO., LTD. (JA) | 1976-07-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008936-A1 | UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX | B2M, MGMT, ITGAM | TGFBR1 89/4885TDP1 3045/4885TET2 2812/4885 |
| US-12552956-B2 | Photopolymerizable type dental surface coating composition | CDH1, DCLRE1A, ITGA1 | TGFBR1 349/4885TDP1 1482/4885TET2 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.